Batimastat

BB 94, Collagenase Inhibitors-1

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Wojtowicz S, Ness E, Dickson R, et al. Phase I trial of batimastat (BB-94), a novel matrix metalloproteinase inhibitor in patients with advanced cancer. J Immunother 1994 Oct; 16: 249
Article Google Scholar
Davies B, Brown PD, East N, et al. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993 May 1; 53: 2087–91
PubMed CAS Google Scholar
Wang X, Fu X, Brown PD, et al. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 1994 Sep 1; 54: 4726–8
PubMed CAS Google Scholar
Chirivi RGS, Garofalo A, Crimmin MJ, et al. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 1994 Aug 1; 58: 460–4
Article PubMed CAS Google Scholar
Taraboletti G, Garofalo A, Belotti D, et al. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 1995 Feb 15; 87: 293–8
Article PubMed CAS Google Scholar
Sledge Jr GW, Qulali M, Goulet R, et al. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 1995 18 Oct; 87: 1546–50
Article PubMed CAS Google Scholar
Marketletter 1994 Mar 21

Batimastat. Drugs R&D 1, 139–141 (1999). https://doi.org/10.2165/00126839-199901020-00005

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.